Streptomycin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Aminoglycoside antibiotic, tuberculostatic.

Half-lifeThis section has been translated automatically.

2,8 h

IndicationThis section has been translated automatically.

Tuberculosis in combination therapies, infections with gram-negative germs, see also gentamicin.

Limited indicationThis section has been translated automatically.

Restricted kidney function.

Dosage and method of useThis section has been translated automatically.

  • Adults: 15 mg/kg bw i.m. or i.v. maximum daily dose 1 g, for patients over 60 years of age max. 0.75 g.
  • Children 30-40 mg/kg bw.

Undesirable effectsThis section has been translated automatically.

Oto-, neuro-, nephrotoxicity, BB changes, allergic skin reactions (about 10% of patients), contact dermatitis (3-10% of patients).

ContraindicationThis section has been translated automatically.

Pregnancy, pre-damage of the vestibular or cochlear organ, terminal renal failure.

PreparationsThis section has been translated automatically.

strepto-fatol, strepto hefa

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer